Exudative hemorrhage after stapling of pulmonary artery during thoracic surgery
Conditions
Interventions
Using PuraStat for exudative hemorrhage after stapling of pulmonary artery during thoracic surgery
Sponsors
Ode Yasuhisa
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Age 18 years or older (2) ECOG performance status (PS) is 0 or 1 (3) Planned surgery is scheduled within 2 weeks (4) Patient is scheduled for an anatomical lung resection (segmentectomy, lobectomy, bilobectomy, pneumonectomy or a combination of these surgical procedures) (5) Major organ function is preserved (6) Written informed consent has been obtained
Exclusion criteria
Exclusion criteria: (1) Patients with a history of coagulation disorder (2) Patients with psychiatric disorders that make it difficult to include in the study (3) Patients receiving continuous systemic administration of steroids or immunosuppressants (4) Patients with a history of hypersensitivity to peptide or protein products (5) Patients with a history of serious hypersensitivity
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Rate of additional hemostatic treatment required | — |
Secondary
| Measure | Time frame |
|---|---|
| Time to achieve hemostasis Rate of additional intraoperative hemostatic treatments required Time required to prepare PuraStat Amount of PuraStat used Duration of chest drainage Drain discharge volume Length of postoperative hospital stay Intraoperative complications Adverse events within 30 days after surgery Rate of postoperative rebleeding | — |
Contacts
Public ContactShinya Katsumata
Shizuoka Cancer Center
Outcome results
None listed